Chris Markoch, Editor & Contributing Author at MarketBeat Articles by Chris Markoch - Page 5May 13, 2024 5:15 AM ETAnheuser-Busch Continues Its Push to Retake the CrownChris MarkochBUD stock rose 7% the week after the company reported solid earnings and expects the Bud Light backlash to be over, but a weak consumer may be a bigger concernNYSE:BUDNYSE:STZRead Anheuser-Busch Continues Its Push to Retake the CrownMay 13, 2024 5:00 AM ETEvolv Technologies Had a Bad Week, Is it Time to Buy or Fade?Chris MarkochEVLV stock fell more than 30% on news that the company is the target of a class-action lawsuit; the news made a bad earnings report look worse than it wasNASDAQ:EVLVRead Evolv Technologies Had a Bad Week, Is it Time to Buy or Fade?May 7, 2024 7:16 AM ETTraders Sell but Investors Still Win After Palantir's EarningsChris MarkochPalantir stock is down sharply after a strong earnings report. The long-term thesis hasn't changed, but it reinforces that PLTR stock is still an active tradeNYSE:PLTRRead Traders Sell but Investors Still Win After Palantir's EarningsMay 3, 2024 7:28 AM ETApple’s Earnings Show Investors Its Strength and Its WeaknessChris MarkochApple stock is up after the company announced a $110 billion share buyback; however, the report did not provide clarity about the company’s direction on AINASDAQ:AAPLNASDAQ:GOOGLRead Apple’s Earnings Show Investors Its Strength and Its WeaknessMay 3, 2024 5:18 AM ETFor Cardinal Health, the Proof Will be in Its PerformanceChris MarkochCAH stock is up after mixed earnings that investors hope is enough to hold support after the company announced its contract for OptumRx will expire in JuneNYSE:CAHNYSE:UNHNYSE:WFCRead For Cardinal Health, the Proof Will be in Its PerformanceApril 30, 2024 7:10 AM ETAnalyst Sentiment, Revenue Growth Will Lead AbbVie Stock HigherChris MarkochAfter falling nearly 6% based on concerns about Humira sales, AbbVie stock is recovering, and bullish analyst sentiment is likely to push the stock higherNYSE:ABBVRead Analyst Sentiment, Revenue Growth Will Lead AbbVie Stock HigherApril 29, 2024 10:29 AM ETWhat Bulls and Bears May Be Getting Wrong about SOFI StockChris MarkochSOFI stock is down nearly 8% in early trading despite a solid earnings report; investors are still trying to get clarity on this polarizing stockNASDAQ:SOFIRead What Bulls and Bears May Be Getting Wrong about SOFI StockApril 26, 2024 7:15 AM ETAlphabet Changes the Narrative with Its First-Ever DividendChris MarkochAlphabet stock is surging after the company delivered a double beat, increased its share buyback program, and announced its first-ever dividendNASDAQ:GOOGLNASDAQ:AAPLNASDAQ:METARead Alphabet Changes the Narrative with Its First-Ever DividendApril 24, 2024 7:07 AM ETGE Aerospace is Ready for Liftoff After Strong EarningsChris MarkochGE stock is up sharply after a double beat; the company will be known as GE Aerospace going forward, and a bullish outlook may raise analysts' price targetsNYSE:GENYSE:GEVRead GE Aerospace is Ready for Liftoff After Strong EarningsApril 11, 2024 9:53 AM ETBullish Earnings Means More of the Same for Constellation BrandsChris MarkochConstellation Brands is moving higher after a double beat driven by higher beer sales and positioning STZ stock to reach all-time highsNYSE:STZNYSE:BUDRead Bullish Earnings Means More of the Same for Constellation BrandsApril 8, 2024 9:55 AM ETWill the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?Chris MarkochJohnson & Johnson's proposed acquisition of Shockwave Medical may be the jolt that JNJ stock needs to break out of a year-long downtrendNYSE:JNJNASDAQ:SWAVNYSE:KVUERead Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?April 2, 2024 9:25 AM ETTesla Stock Drops on Weak Delivery Numbers and it May Fall MoreChris MarkochTesla stock dropped nearly 6% after the company reported lighter-than-expected delivery numbers, further fueling concerns about the stock's valuationNASDAQ:TSLANASDAQ:GOEVNYSE:FSRRead Tesla Stock Drops on Weak Delivery Numbers and it May Fall MoreMarch 25, 2024 9:10 AM ETShould You Buy Boeing Stock After CEO Resignation Announcement?Chris MarkochBoeing stock is up slightly after announcing its CEO was stepping down at the end of the year, but it may not change the short-term outlook for BA stockNYSE:BANASDAQ:QCOMNYSE:DBRead Should You Buy Boeing Stock After CEO Resignation Announcement?March 20, 2024 8:26 AM ETChipotle Stock Shoots Higher, Announcing 50 for 1 Stock SplitChris MarkochChipotle stock is approaching a new record high after announcing a 50-for-1 stock split which will make CMG shares more accessible for retail investorsNYSE:CMGNYSE:WMTNYSE:BRK.ARead Chipotle Stock Shoots Higher, Announcing 50 for 1 Stock SplitMarch 19, 2024 5:08 AM ETArcher-Daniels Midland Stock is Rock Steady, but is it a Buy?Chris MarkochArcher-Daniels Midland stock is up more than 8% despite soft earnings and weak guidance; the company shed some light on a DOJ accounting probeNYSE:ADMRead Archer-Daniels Midland Stock is Rock Steady, but is it a Buy?March 15, 2024 12:35 PM ETWhy Dollar General and Dollar Tree Are Similar Yet DifferentChris MarkochDollar General and Dollar Tree issued different earnings reports that showed their core lower-income consumers remain under pressureNYSE:DGNASDAQ:DLTRRead Why Dollar General and Dollar Tree Are Similar Yet DifferentMarch 12, 2024 7:45 AM ETGameStop Stock Is Giving Investors a Familiar Feeling, But Why?Chris MarkochA recent spike in GameStop stock may give investors a familiar feeling, but before getting involved, they should see if there's substance behind the surgeNYSE:GMERead GameStop Stock Is Giving Investors a Familiar Feeling, But Why?March 6, 2024 10:33 AM ETPalantir Stock Spikes 6% on U.S. Army TITAN ContractChris MarkochPalantir stock is surging to three-year highs on news of a $178 million contract from the U.S. Army; but the real catalyst may be coming at its AIPCon eventNYSE:PLTRRead Palantir Stock Spikes 6% on U.S. Army TITAN ContractMarch 6, 2024 5:15 AM ETBUD Stock Reverses on Lower Bud Light Sales, Is the Bottom In?Chris MarkochAnheuser-Busch stock is down over 4% after mixed earnings reveal it still has a Bud Light problem; the company's turnaround relies on more fundamental factorsNYSE:BUDRead BUD Stock Reverses on Lower Bud Light Sales, Is the Bottom In?March 5, 2024 5:08 AM ETIs UnitedHealth Group Stock a Strong Buy or a Falling Knife?Chris MarkochAfter two weeks of bad news that has erased almost a year of gains, interested buyers may want to wait for confirmation of support before buying UNH stockNYSE:UNHNASDAQ:PANWNYSE:HUMRead Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?March 5, 2024 5:00 AM ETCathie Wood Likes UiPath Stock Over NVDA, Should You?Chris MarkochAlthough Cathie Wood sold Nvidia in 2023, she continues to invest in artificial intelligence via her long position in UiPath stockNYSE:PATHNASDAQ:NVDANYSEARCA:ARKKRead Cathie Wood Likes UiPath Stock Over NVDA, Should You?March 1, 2024 7:23 AM ETWhat Dip, Nu Holdings Stock Continues to Rise After Earnings MissChris MarkochNu stock continues to rise after a solid earnings report, but with the stock reaching an overbought technical point, investors may soon get a buyable dipNYSE:NUNASDAQ:PYPLNASDAQ:SOFIRead What Dip, Nu Holdings Stock Continues to Rise After Earnings MissFebruary 28, 2024 6:45 AM ETCars.com and Carvana Stock Facing Weaker Consumer SentimentChris MarkochCars.com and Carvana Co. give investors two different ways to play the retail automotive market, but the two automotive stocks are behaving very differentlyNYSE:CARSNYSE:CVNARead Cars.com and Carvana Stock Facing Weaker Consumer SentimentFebruary 21, 2024 1:03 PM ETTeladoc Health gaps down to support level after weak guidanceChris MarkochTeladoc Health stock is down more than 22% after the company delivered a poor outlook for 2024 that has investors questioning future growth prospectsNYSE:TDOCRead Teladoc Health gaps down to support level after weak guidance Page 5 of 40 « Most Recent‹ More Recent2345678 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
